Mirtazapine Tablet
Product Images NDC 71335-2963

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 71335-2963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

Chemical structure diagram of the active ingredient mirtazapine, showing its molecular framework with characteristic fused rings and a methyl group attached to a nitrogen atom.*

FDA Label Image

Label (Lbl713352963)

Mirtazapine Tablets, USP 30 mg oral tablets label. Package contains 500 tablets. Label shows the product NDC 71335-2963-1 and includes storage instructions, pharmacist information, and QR codes for package insert. Repackaged by Bryant Ranch Prepack, Inc., Burbank, CA, and manufactured by ALKALOID Chemical Company Zrt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.